Search Results 2971-2980 of 25632 for oral

  1. Preoperative Prayer Into Ambulatory Surgical Patients’ Experience and Its Impact on Patient Anxiety and Satisfaction - Mayo Clinic

    Able to give oral consent. Exclusion Criteria: Surgical outpatients < 18 years of age. Unable to read and speak English OR unable to communicate using ...

  2. Kiaran P. McGee, Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Oral ExaminerAmerican Board of Radiology. 2015 - 2018. MemberRadiologic Physics Oral Boards Examiner, American Board of Radiology. 2014 - 2017. MemberAmerican ...

  3. Keloid scar - Diagnosis and treatment - Mayo Clinic

    Wound care. For newer keloids, the first treatment option might be compression dressings made from stretchy fabric or other materials. · Corticosteroid cream.

  4. Tricyclic antidepressants - Mayo Clinic

    Tricyclic antidepressants can have more side effects than other antidepressants. But for some people, they may ease depression when other medicines fail.

  5. Publications - Clark C. Otley, M.D. - Mayo Clinic

    Oral retinoids for chemoprevention of skin cancers in organ transplant recipients: results of a survey. Transplant Proc. 2006 Jun; 38(5):1366-8. View PubMed ...

  6. Using a Web-Based Data Base System to Improve Patient Outcomes in Postural Orthostatic Tachycardia Syndrome - Mayo Clinic

    Mayo Clinic Arizona patients who do not sign Certificate of Confidentiality form and give oral consent; Person unable to give information for completion of ...

  7. HPV Infection Clinical Trials - Mayo Clinic Research

    ... oral or throat HPV infection. It is also unknown if certain sexual behaviors increase the risk of oral HPV infection. Female Patients and Female Partners ...

  8. A Study of Pembrolizumab Alone or Combined with CC-486 for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer - Mayo Clinic

    The purpose of the study is to determine the best dose of CC-486 (oral azacitidine) combined with pembrolizumab for the treatment of platinum-resistant ...

  9. TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study - Mayo Clinic

    ... oral contraceptive. Hormonal contraception must be started at least 1 full cycle prior to Baseline and continue for 180 days after the last dose of ...

  10. Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism - Mayo Clinic

    ... oral calcium supplements between the two measurements. Thyroid-stimulating ... Use of oral bisphosphonates within 6 months of screening or intravenous ...